Sait Ashina, MD
Dr. Ashina specializes in the treatment of headache conditions, including chronic and intractable migraine and cluster headache. His headache treatment approach combines drug therapy, interventional treatments such as nerve blocks, Botulinum toxin injections, trigger point injections, and inpatient and outpatient infusion therapy. Dr. Sait Ashina is an Attending physician and Neurologist at the Department of Neurology at Mount Sinai Beth Israel. He is a Headache Specialist and a Director of the Headache Program at Mount Sinai Beth Israel. Dr. Ashina earned his medical degree at the University of Copenhagen, Denmark. He completed medical internship at the Hospital of Saint Raphael affiliated with Yale University School of Medicine in New Haven, CT. He did his residency in neurology at the Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY. He received training in Headache Medicine at the Montefiore Headache Center in Bronx, NY and the Danish Headache Center, Copenhagen, Denmark. Dr. Ashina is a Diplomat of the American Board of Psychiatry and Neurology and a Diplomat in Headache Medicine through the United Council for Neurological Subspecialties. He is a member of education committee of International Headache Society and is Fellow of American Headache Society. Dr. Ashina also served as a member of the International Headache Society headache classification subcommittee on Tension-Type Headache for the 3rd edition of the International Classification of Headache Disorders (ICHD-3). He is also an Associate Editor of Neurology Reviews, and a Visiting Editor of the Journal of Headache and Pain. He has won several awards for his work, including the Clinical Headache Fellowship Award from the American Headache Society. He is a recipient of prestigious 2012 Enrico Greppi Award endorsed by the European Headache Federation and the Italian Society for the Study of Headaches. Dr. Ashina has also been named to the Super Doctors 2013 and 2014 New York Rising Stars list. His research interest includes epidemiology of headache and chronic pain, quantitative sensory testing and human pain models.